|
|
|
|
 |
 |
|
* Today's Sector Analysis: "Drugs " Institutional Technical Viewpoint
Buy Alert!
Watson Pharmaceuticals
(WPI):
$83.88 Stop. $81.38 P-Stop $99.50 P-Objective
Dow Jones Ind: 13,157.97 plus 100.51 points Aug 24, 2012 * Price Objective: 13,800
Volume Two No. 2443
|
TICKER
|
COMPANY NAME
|
BUY!
SELL
|
RSI INDEX
* OPTIONS
|
ENTRY
PRICE
|
STOPS
8/27/12
|
PRICE
OBJ
|
CLOSE
PRICE
|
|
ALOG
|
ANALOGIC CORP
|
BUY!
|
* RSI: 69.12
|
$69.75
|
$67.25
|
$83.50
|
$69.30
|
|
AN
|
AUTONATION INC
|
BUY!
|
* RSI: 63.04
|
$40.75
|
$38.75
|
$48.00
|
$40.52
|
|
CROX
|
CROX INC
|
BUY!
|
* RSI: 61.87
|
$17.88
|
$16.38
|
$25.00
|
$17.65
|
|
DTV
|
THE DIRECTV GROUP
|
BUY!
|
* RSI: 68.71
|
$52.88
|
$50.38
|
$63.00
|
$52.63
|
|
FCFS
|
FIRST CASH FINANCIAL SVC
|
BUY!
|
* RSI: 68.71
|
$44.88
|
$42.88
|
$57.50
|
$44.47
|
|
MDAS
|
MEDASSETS INC
|
BUY!
|
* RSI: 72.49
|
$17.25
|
$15.75
|
$29.50
|
$17.00
|
|
MHO
|
M/I HOMES INC
|
BUY!
|
* RSI: 64.38
|
$19.50
|
$18.13
|
$27.00
|
$19.33
|
|
MMS
|
MAXIMUS INC
|
BUY!
|
* RSI: 64.78
|
$54.38
|
$51.88
|
$62.50
|
$54.00
|
Drugs
CLDX: $5.12 GERN: $2.35 SNSS: $3.39
|
Buy Alerts
BIOS: $8.03 FVE: $4.67 TWMC: $3.51
|
|
CUBIST PHARMACEUTICALS
(CBST-Nasdaq):
Technical Viewpoint: From a low
of $41.89 on Aug 2, 2012 prices
rallied, reaching a
high of $44.57
on Aug 10, 2012. A
decline saw prices pull back, reaching a
low of
$42.65 on Aug 17, 2012.
Another rally saw prices penetrate
resistance, closing 8/24/12
at $45.65. Technicals: MACD Index (MACD): A Buy Alert!
was given on Aug 24, 2012 when the solid line crossed the dotted line to the upside.
Support: Remains at $44.57. Resistance: Is at None at current levels.
Point & Figure: Reversed to the upside on Jul 12, 2012. A P&F upside
reversal takes place at $43.00. Summary: Technical indicators have turned bullish. BUY! CUBIST PHARMACEUTICALS
(CBST-Nasdaq) @ $46.13 Stop: Use a protective stop of $44.13.
CUBIST PHARMACEUTICALS is currently trading @ $45.65 plus $1.21 on Aug 24, 2012. Price Objective:
$57.50. Risk/Reward: $2.00 VS. $13.37. Today's Risk Reward Ratio: 6:1
|
Click here to view full size chart
|
|
|
|
 |
|
|
DISCLAIMER: This report is not intended as an offering or a solicitation of an offer to buy or sell the securities and futures mentioned. While all information is derived from sources we deem reliable, we do not represent that it is accurate or complete. Such information and the opinions expressed are subject to change without notice. WALL STREET TRADER'S COLUMN, its officers, stockholders, and employees and their families may have a long or short position in or may at any given time purchase or sell the securities or options relating thereto <
|
|